Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Similar articles for PubMed (Select 24658154)

1.

Recognition and killing of autologous, primary glioblastoma tumor cells by human cytomegalovirus pp65-specific cytotoxic T cells.

Nair SK, De Leon G, Boczkowski D, Schmittling R, Xie W, Staats J, Liu R, Johnson LA, Weinhold K, Archer GE, Sampson JH, Mitchell DA.

Clin Cancer Res. 2014 May 15;20(10):2684-94. doi: 10.1158/1078-0432.CCR-13-3268. Epub 2014 Mar 21.

2.

Cytomegalovirus-specific cytolytic T-cell lines and clones generated against adenovirus-pp65-infected dendritic cells.

Keever-Taylor CA, Margolis D, Konings S, Sandford GR, Nicolette CA, Lawendowski C, Burns WH.

Biol Blood Marrow Transplant. 2001;7(5):247-56.

3.

Transfection of dendritic cells with in vitro-transcribed CMV RNA induces polyclonal CD8+- and CD4+-mediated CMV-specific T cell responses.

Heine A, Grünebach F, Holderried T, Appel S, Weck MM, Dörfel D, Sinzger C, Brossart P.

Mol Ther. 2006 Feb;13(2):280-8. Epub 2005 Oct 10.

PMID:
16219490
4.

The detection of CMV pp65 and IE1 in glioblastoma multiforme.

Lucas KG, Bao L, Bruggeman R, Dunham K, Specht C.

J Neurooncol. 2011 Jun;103(2):231-8. doi: 10.1007/s11060-010-0383-6. Epub 2010 Sep 5.

PMID:
20820869
5.

Strategic use of an adenoviral vector for rapid and efficient ex vivo-generation of cytomegalovirus pp65-reactive cytolytic and helper T cells.

Forsberg O, Carlsson B, Tötterman TH, Essand M.

Br J Haematol. 2008 Apr;141(2):188-99. doi: 10.1111/j.1365-2141.2008.07026.x. Epub 2008 Feb 26.

PMID:
18307565
6.

Simultaneous generation of cytomegalovirus-specific CD8+ and CD4+ T lymphocytes by use of dendritic cells comodified with pp65 mRNA and pp65 protein.

Carlsson B, Hou M, Giandomenico V, Nilsson B, Totterman TH, Essand M.

J Infect Dis. 2005 Dec 1;192(11):1912-20. Epub 2005 Oct 21.

7.

Identification of HLA-A24-restricted CTL epitope encoded by the matrix protein pp65 of human cytomegalovirus.

Akiyama Y, Maruyama K, Mochizuki T, Sasaki K, Takaue Y, Yamaguchi K.

Immunol Lett. 2002 Aug 1;83(1):21-30.

PMID:
12057851
9.

Expansion of T cells targeting multiple antigens of cytomegalovirus, Epstein-Barr virus and adenovirus to provide broad antiviral specificity after stem cell transplantation.

Hanley PJ, Shaffer DR, Cruz CR, Ku S, Tzou B, Liu H, Demmler-Harrison G, Heslop HE, Rooney CM, Gottschalk S, Bollard CM.

Cytotherapy. 2011 Sep;13(8):976-86. doi: 10.3109/14653249.2011.575356. Epub 2011 May 4.

10.

CMV-independent lysis of glioblastoma by ex vivo expanded/activated Vδ1+ γδ T cells.

Knight A, Arnouk H, Britt W, Gillespie GY, Cloud GA, Harkins L, Su Y, Lowdell MW, Lamb LS.

PLoS One. 2013 Aug 7;8(8):e68729. doi: 10.1371/journal.pone.0068729. eCollection 2013.

11.

[CMV pp65 gene modified dendritic cells activate autologous T cells].

Gao GX, Chen XQ, Zhang JY, Zhu HF, Dong BX, Gu HT, Gao Y, Pan YZ.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Apr;16(2):397-400. Chinese.

PMID:
18426673
12.

The matrix protein pp65(341-350): a peptide that induces ex vivo stimulation and in vitro expansion of CMV-specific CD8+ T cells in subjects bearing either HLA-A*2402 or A*0101 allele.

Provenzano M, Lim JB, Mocellin S, Monsurro V, Bettinotti M, Marincola FM, Stroncek DF.

Transfusion. 2003 Nov;43(11):1567-74.

PMID:
14617317
13.

Generation of polyclonal CMV-specific T cells for the adoptive immunotherapy of glioblastoma.

Ghazi A, Ashoori A, Hanley PJ, Brawley VS, Shaffer DR, Kew Y, Powell SZ, Grossman R, Grada Z, Scheurer ME, Hegde M, Leen AM, Bollard CM, Rooney CM, Heslop HE, Gottschalk S, Ahmed N.

J Immunother. 2012 Feb-Mar;35(2):159-68. doi: 10.1097/CJI.0b013e318247642f.

14.

Characterization of cytomegalovirus pp65-HLA-A24 peptide-specific CTL lines from metastatic melanoma patients.

Akiyama Y, Tai S, Komiyama M, Takikawa M, Ohshita C, Yamamoto A, Yamazaki N, Kiyohara Y.

Oncol Rep. 2009 Jul;22(1):185-91.

PMID:
19513522
15.

A canarypox vector-expressing cytomegalovirus (CMV) phosphoprotein 65 induces long-lasting cytotoxic T cell responses in human CMV-seronegative subjects.

Berencsi K, Gyulai Z, Gönczöl E, Pincus S, Cox WI, Michelson S, Kari L, Meric C, Cadoz M, Zahradnik J, Starr S, Plotkin S.

J Infect Dis. 2001 Apr 15;183(8):1171-9. Epub 2001 Mar 13.

16.

Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus-specific cytotoxic T lymphocytes.

McLaughlin-Taylor E, Pande H, Forman SJ, Tanamachi B, Li CR, Zaia JA, Greenberg PD, Riddell SR.

J Med Virol. 1994 May;43(1):103-10.

PMID:
8083644
17.

B lymphoblastoid cell lines as efficient APC to elicit CD8+ T cell responses against a cytomegalovirus antigen.

Sun Q, Burton RL, Dai LJ, Britt WJ, Lucas KG.

J Immunol. 2000 Oct 1;165(7):4105-11.

18.

Expansion of cytomegalovirus pp65 and IE-1 specific cytotoxic T lymphocytes for cytomegalovirus-specific immunotherapy following allogeneic stem cell transplantation.

Bao L, Dunham K, Stamer M, Mulieri KM, Lucas KG.

Biol Blood Marrow Transplant. 2008 Oct;14(10):1156-62. doi: 10.1016/j.bbmt.2008.07.014.

19.
20.

Integrase-defective lentiviral vectors encoding cytokines induce differentiation of human dendritic cells and stimulate multivalent immune responses in vitro and in vivo.

Daenthanasanmak A, Salguero G, Borchers S, Figueiredo C, Jacobs R, Sundarasetty BS, Schneider A, Schambach A, Eiz-Vesper B, Blasczyk R, Weissinger EM, Ganser A, Stripecke R.

Vaccine. 2012 Jul 20;30(34):5118-31. doi: 10.1016/j.vaccine.2012.05.063. Epub 2012 Jun 9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk